Text-message Reminders to Increase Rates of Postpartum Diabetes Screening

Status Terminated

Clinical Trial Summary

Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery.

Study Design: Prospective randomized control trial

Hypothesis: Gestational diabetics will be significantly more likely to follow up with their postpartum screening for diabetes if they receive text-message reminders to set up their lab appointment compared to those who receive usual care.

Clinical Trial Description

Eligible participants will be recruited after delivery while on the postpartum ward. Recruitment will be conducted by the PI or a member of the study team. After informed consent is obtained, the patients will be randomized into one of two study groups: the intervention group or the control group. Women in the intervention group will receive a test text-message reminder at the time of enrollment. They will then receive a text-reminder to schedule their oral glucose tolerance test at 6 weeks postpartum, with further reminders at 3 months and 6 months if they have not completed their testing. Women in the control group will only receive the test text-message reminder. The PI or member of the study team obtaining the informed consent will verify the participant has received the text-message prior to completing enrollment. A computer-generated randomization list will be generated according to intervention vs. control group. Simple randomization will be used for the purposes of this study. 316 participants will be recruited based on the sample size calculations already performed. One group of 316 randomized opaque envelopes will be prepared. These sealed envelopes will be stored in a secured designated area at Tampa General Hospital. Once a patient has agreed to participate and is consented an envelope will be selected from the next sequentially numbered envelope and the number on the envelope will be recorded on their study sheet. Enrollment will continue until 316 participants have been recruited. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02013557
Study type	Interventional
Source	University of South Florida
Contact
Status	Terminated
Phase	N/A
Start date	January 2014
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting	`NCT06437782` - Exploration of Health Literacy in Diabetes in Reunion Island and France
Completed	`NCT01940003` - Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial	N/A
Completed	`NCT02960295` - The Virtual Visit for Women With Gestational Diabetes	N/A
Completed	`NCT01919476` - Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women	N/A
Completed	`NCT05512871` - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)	N/A
Enrolling by invitation	`NCT03307486` - Gestational Diabetes: a Cohort Study	N/A
Active, not recruiting	`NCT04417452` - Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
Completed	`NCT02968628` - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Active, not recruiting	`NCT04222348` - MeDiGes Study: Metformine Use in Gestational Diabetes	Phase 3
Completed	`NCT03007186` - Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Completed	`NCT00069576` - Gestational Diabetes Mellitus Trial (GDM)	N/A
Completed	`NCT04866823` - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes	N/A
Recruiting	`NCT04198857` - Development and Testing of a Mobile Health Application for Management of Gestational Diabetes	N/A
Recruiting	`NCT05115188` - DIAgnosing GDM usiNg Oral Sugar InStead	Phase 2
Recruiting	`NCT03607799` - A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes	N/A
Recruiting	`NCT02893072` - Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study	N/A
Enrolling by invitation	`NCT05368220` - Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Completed	`NCT02770079` - Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
Completed	`NCT00681460` - Metformin in Gestational Diabetes Mellitus	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms